【摘 要】
：
Objective Most DAVFs can be treated safely and effectively with endovascular Onyx embolization.We report our experience in balloon-assisted endovascular Onyx embolization of intracranial dural arterio
【出 处】
：
首都医科大学2013年研究生学术论坛
论文部分内容阅读
Objective Most DAVFs can be treated safely and effectively with endovascular Onyx embolization.We report our experience in balloon-assisted endovascular Onyx embolization of intracranial dural arteriovenous fistulas (DAVFs).Materials and Methods Clinical records of 6 DAVFs patients (two women, four men) treated with balloon-assisted endovascular Onyx embolization were retrospectively collected to analysis their presenting symptoms, angiographic features, endovascular treatments, and clinical outcomes.
其他文献
目的：了解ACS患者出院6个月医生对指南推荐二级预防药物的开药情况、病人的使用情况及相关因素.方法：对102例ACS的患者进行临床资料的登记和分析,半年后通过电话进行随访；根据患者在出院后6个月的处方药分为使用组和未使用组,并对其影响因素进行统计分析.结果：①抗血小板药、β受体阻滞剂、ACEI/ARB和他汀类药物的开药率,在出院带药时分别为96.1％、67.6％、53.9％、83.3％；出院后3个
We investigated the genetic structure of 120 isolates of serotype 19F Streptococcus pneumonia from chinese children with acute respiratory infections collected prior and post to the administration of
The combination of Bevacizumab and Irinotecan is a new chemotherapy for recurrent glioblastoma multiforme (GBM).Recent phase Ⅱ trials suggest this combined chemotherapy is beneficial to patients, but
Background: Studies from around the world report that the characteristics of hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) are changing because of the invasion of community
目的 探讨动脉瘤介入患者Hunt-Hess分级、性别及年龄对介入并发症及预后的影响，为动脉瘤介入治疗的进一步稳定发展提供理论及临床依据.方法 收集神经外科动脉瘤患者资料42例，探讨动脉瘤患者Hunt-Hess分级、性别及年龄对介入并发症和预后的影响.结果 Hunt-Hess低分级与高分级患者并发症发生率差异显著，男女患者并发症比较无显著性差异；＜60岁患者与≥60岁患者并发症无显著性差异.Hunt
The endovascular treatment of wide-necked aneurysms remains challenging.The development of self-expanding intracranial stent has increased the options for the treatment of wide-necked aneurysms.In tre
目的 探讨经血管内治疗的老年脑动脉瘤患者临床资料及预后,分析血管内治疗的疗效.方法 回顾性分析38例经血管内治疗的60岁以上脑动脉瘤患者,总结老年脑动脉瘤患者的临床特点,介入治疗方式及临床并发症,按照改良Rankin量表评分标准评价预后,其中0-3分为预后佳,4-6分为预后差.结果 38例脑动脉瘤患者中共计脑动脉瘤42个,41个被成功栓塞.38例患者中90％以上患有高血压或糖尿病等基础疾病.术后3
目的：研究脂蛋白(Lp)(a)血清浓度和载脂蛋白(apo)(a)基因5调控区-914G/A多态性与颅内动静脉畸形的相关性.方法：运用聚合酶链式反应一限制性内切酶片段长度多态性技术(PCR-RFLP),对57名患者和60名对照者的apo(a)基因5调控区-914G/A多态性进行检测,并研究其对血脂水平的影响和与颅内动静脉畸形的相关性.结果：总研究组的apo (a)基因5调控区-914G/A多态性的A
目的 应用复制缺陷型腺病毒载体系统构建结缔组织生长因子(CTGF)重组腺病毒载体,转染血管平滑肌细胞(VSMCs),观察CTGF高表达对VSMCs迁移的影响.方法 将CTGF基因整合入腺病毒穿梭质粒pAdTrack-CMV中,构建重组穿梭质粒pAdTrack-CTGE线性化后与pAdeasy-1在大肠杆菌BJ5183中进行同源重组,获得含目的基因的重组体质粒pAd-CTGB酶切后用转染HEK293
目的：通过探讨尼莫地平对动脉瘤性蛛网膜下腔出血后脑血管痉挛的临床疗效，为应用尼莫地平防治动脉瘤性蛛网膜下腔出血后脑血管痉挛提供临床依据.方法：回顾性分析动脉瘤性蛛网膜下腔出血患者临床资料156例，分为尼莫地平组和对照组，两组均给予绝对卧床，止血，脱水及对症治疗，尼莫地平组加用尼莫地平持续泵注，观察脑血管痉挛率及病死率.结果：156例均行动脉瘤栓塞术，术后2周内尼莫地平组脑血管痉挛发生率及病死率低，